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In the past few years, several papers have been published in the international literature on the 
impact of the economic crisis on health and health care. However, there is limited knowledge 
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on this topic regarding the Central and Eastern European (CEE) countries. The main aims of 
this study are to examine the effect of the financial crisis on health care spending in four CEE 
countries (the Czech Republic, Hungary, Poland and Slovakia) in comparison with the OECD 
countries. In this paper we also revised the literature for economic crisis related impact on 
health and health care system in these countries. OECD data released in 2012 were used to 
examine the differences in growth rates before and after the financial crisis. We examined the 
ratio of the average yearly growth rates of health expenditure expressed in USD (PPP) 
between 2008-2010 and 2000-2008. The classification of the OECD countries regarding 
“development” and “relative growth” resulted in four clusters. A large diversity of “relative 
growth” was observed across the countries in austerity conditions, however the changes 
significantly correlate with the average drop of GDP from 2008 to 2010. To conclude, it is 
difficult to capture visible evidence regarding the impact of the recession on the health and 
health care systems in the CEE countries due to the absence of the necessary data. For the 
same reason, governments in this region might have a limited capability to minimize the 
possible negative effects of the recession on health and health care systems. 
 
Key words: austerity, recession, health, heath care, Central-Eastern Europe, Czech Republic, 
Hungary, Poland, Slovakia 
JEL-code: I15 
 
1. Introduction 
Due to the financial crisis and the subsequent economic crisis, in 2009 many countries 
experienced a large decrease in gross domestic product (GDP). In the European Union’s (EU) 
27 member countries the average decrease of real GDP was 4.3% according to EUROSTAT 
data. Financial and economic distress has already had wide-reaching social and political 
consequences, including falling incomes, growing inequalities and huge increases in 
unemployment (WHO 2013). Many countries implemented austerity policies and where 
bailouts were needed financial rescue packages were set, with controversial results 
(Karanikolos et al. 2013). The need for a shift towards restoring sound fiscal conditions has 
often implied substantial cuts in public spending (OECD 2013). Health care was one field of 
these budget cuts. Austerity conditions impacted both public and private expenditure on 
health care, and the continuous growth of health expenditure was halted (OECD 2013; WHO 
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2013; Klazinga 2012). The drop in the growth of health expenditure might have uncertain 
impacts on the health and well-being of the population and cause challenges for governments 
to maintain the scope and quality of health care services.  
In the past few years, several papers have been published in the literature on the impact of the 
economic crisis on health and health care. Some of the papers examined the effect of the 
economic crisis on health outcomes and behaviour (e.g. mortality rates, suicide rates, alcohol 
consumption) (e.g. Stuckler et al. 2011), while others presented the reform measures 
implemented in the countries as a response to the financial crisis (e.g. Karanikolos et al. 2013; 
Rechel et al. 2013). Numerous papers focussed on Greece and on countries which were more 
affected by the recession (e.g. Kousoulis 2013; Vandoros et al. 2013).  
However, there is limited knowledge on the impact of the economic recession on health and 
health care in the Central and Eastern European (CEE) countries, although these countries 
might have been effected similarly, or even more severely than high income countries. In the 
CEE member states of the EU, which joined in 2004 or after, the average drop in GDP was 
almost twice as the drop in countries in the euro-zone (-4.4%). Except for Poland, all of these 
countries experienced recession, with losses ranging from 4.5% in the Czech Republic to 
17.7% in Latvia. 
Also, most of these countries have been struggling with the deficit of the health care budget 
for the last two decades, during which sequences of health care reforms were implemented to 
contain costs with doubtful success (Gaál et al. 2011; Boncz et al. 2006; Boncz et al. 2004; 
Gulácsi et al. 2002; Baji et al. 2012). For these countries the economic crisis is now another 
challenge to deal with. 
This paper aims to review and analyse the evidence on the impact of recession in four CEE 
countries, namely the Czech Republic, Hungary, Poland, Slovakia, often called the Visegrád 
group. The main objective of the paper is to analyse the effect of the financial crisis on health 
care spending in these countries compared to the average of Organisation for Economic Co-
operation and Development (OECD) member states. We aim to examine how the four CEE 
countries compare to other OECD countries in terms of changes in health care expenditure 
after the economic recession. We are also interested how the changes of health expenditure in 
these countries compare to the other OECD countries and also whether the drop of GDP in the 
OECD countries is associated with the decrease of health care expenditure.  
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2. Methods 
To examine the effect of the financial crises on health care spending in different OECD 
countries, we use the OECD’s health data released in 2012. The dataset contains data related 
to health expenditure, health care resources, health care activities, health status as well as risk 
factors for 34 countries. The analysis was carried out in Stata 11. 
To examine the differences in growth rates before and after the financial crisis, a “relative 
growth” component was developed, which indicates the ratio between the annual growth rates 
of health expenditure in USD purchasing power parity (PPP) between 2008 and 2010 (the 
average of 2008/09 and 2009/10 growth rate) and the average annual growth rate of health 
expenditure between 2000 and 2008 (the average of growth rates for 2000/01, 2001/02, 
2002/03, 2003/04, 2004/05, 2005/06, 2006/2007 and 2007/08). This measure can capture the 
short term impact of the economic recession on the growth of health expenditure by indicating 
the relation between the growth of health expenditure before and after the economic crisis.  
The “relative growth” component is ≥1 when the growth of health expenditure after the crisis 
is equal to or greater than the average growth rate before the crisis. It is <1 & ≥0 when health 
expenditure continued to grow, although at a lower rate, or stagnated after the crisis (i.e. 
positive, but lower growth rate for the period 2008 to 2010). It is <0 when health expenditure 
started to decrease after the financial crises.  
To examine differences between countries with different health expenditure structure, a 
“development” component was created by using principal component analysis (PCA) which 
suppresses information on the main characteristics of the health care system (health 
expenditure and life expectancy) of a country. PCA is a frequently applied method in the 
literature on health economics to reduce the dimensions of different health and health care 
indicators, as these indicators are often strongly correlated (See the most famous examples in: 
van der Gaag – Wolfe 1991; Wagstaff 1986). The “development component” used in this 
paper also reduces dimensions of three of the most important input and outcome indicators, 
and captures them in one factor,” As for input indicators we included per capita expenditure 
on health care as well as the share of GDP spent on health care – these are the most frequently 
applied measures of health expenditure (Gerdtham – Jönsson 2000). We also found it useful 
to include an outcome indicator, life expectancy, in the PCA. Due to the limited number of 
observations (34 OECD countries) it is not suggested to use more variables in the PCA 
analysis, to maintain the adequate degree of freedom for the estimations. The component is 
supposed to capture the most important differences across countries regarding health care 
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financing, and provide more valid conclusions than the separate use of the variables. The 
following data from OECD Health Data 2012 were used for the PCA analysis: 
- health expenditure as a percent of GDP in 2010 or the latest available year,1 
- expenditure on health care in USD PPP in 2010 or the latest available year,2 
- life-expectancy in 2010 or the latest available year.3  
 
This principle component (“development”) explains 73.1% of the variance of the three 
variables. The details of the PCA analysis can be found in Appendix 1. We used this 
component to generate a “development” score for each country, which was then standardized, 
i.e. the variable was rescaled to a mean of zero and a standard deviation of one. In this way 
positive values indicate countries with higher expenditure (both as a percent of GDP and in 
real terms) and higher life expectancy, while negative scores indicate the opposite.  
Finally, in the dimension of the two new variables created (the “relative growth” component 
and the “development score”) we carried out a hierarchical cluster analysis to distinguish 
different groups of countries. For this cluster analysis we used the Ward method, which 
ensures homogeneity and relatively equal sizes of the groups. Differences between the 
variables were calculated using the method of Euclidean-distance. 
 
3. Results  
As a result of the economic crisis the positive growth of real health care spending per capita 
(USD, PPP) was halted in the majority of the OECD countries, and in some countries the 
expenditure started to decline. Figure 1 shows the average growth rates of real health 
expenditure per capita of the OECD countries before (from 2000 till 2008) and after (from 
2008 till 2010). Hungary experienced a decrease in health expenditure after 2008 (-0.7%). 
While in Slovakia and the Czech Republic, the average growth rate slowed after the crises, 
but remained relatively high (3.8% and 5.6% respectively), compared to other OECD 
countries. 
 
                                                          
1
 Australia 2009, Japan 2009, Luxemburg 2009, Turkey 2008. 
2
 Australia 2009, Japan 2009, Luxemburg 2009, Turkey 2008. 
3
 Italy 2009, Canada 2008. 
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Figure 1 The average growth rates of real health expenditure per capita before (from 2000 to 
2008) and after (from 2008-2010) 
 
Source: OECD health data 2012, based on Klazinga (2012). 
 
Figure 2 shows the countries in the dimensions of the “relative growth” component (“y” axis) 
and the standardized “development score” component (“x” axis). The “x” axis indicates the 
standardized values of the scores of countries on the “development” component created by 
PCA. Negative values are associated with lower expenditure (both as a percent of GDP as 
well as in real terms), and lower life expectancy, positive values mean the opposite. The “y” 
axis indicates the “relative growth” component, as described in the methods section. 
We have not found significant correlation between the “development” component and the 
relative growth rate of health expenditure per capita.
4
 This suggests that countries with similar 
health expenditure structures reacted quite differently to the crises. This finding supports the 
need for cluster analysis, to create homogenous clusters to further explore the changes in 
health expenditure. 
Out of the 34 OECD countries, 32 countries were classified into four different clusters (See 
Figure 2): 
- Cluster 1: Australia (AUS), Canada (CA), Japan (J), New Zealand (NZ) and 
Switzerland (CH),  
                                                          
4
 The correlation is 0.2182, p=0.2226 for all 33 observations, the correlation is 0.2867 p=0.1179 if we exclude 
USA and Luxemburg from the analysis as outliers. 
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- Cluster 2: Austria (A), Belgium (B), Denmark (DK), France (F), Germany (G), The 
Netherlands (NL), Norway (N), Sweden (S), United Kingdom (UK) and the United 
States (US). 
- Cluster 3: Czech Republic (CZ), Estonia (EST), Hungary (H), Poland (PL), Slovakia 
(SK), Mexico (MEX), South-Korea (ROK), and Chile (RCH). 
- Cluster 4: Finland (FIN), Greece GR), Italy (I), Ireland (IRL), Island (IL), Israel (IS), 
Portugal (P), Slovenia (SLO) and Spain (E). 
Luxemburg was excluded from the cluster analysis as an outlier, because it would have 
formulated a single group itself. Turkey was also excluded due to missing data. 
 
Figure 2. Classification of the OECD countries regarding “development” and “relative 
growth” 
 
Note: The X axis indicates the standardized “development” principal component. The Y axis indicates the 
relative growth rate of health expenditure per capita (the average annual growth rate after the crises between 
2008 and 2010 divided by the average annual growth rate between 2000 and 2008. 
 
These clusters significantly differ in terms of health expenditure as a percent of GDP, health 
expenditure in real terms, life expectancy, the ratio of the average growth rate of health 
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expenditure from 2000 to 2008, and from 2008 to 2010. Descriptive statistics of the four 
clusters and the results of an ANOVA analysis are presented in Table 1. 
Countries in the first two clusters have the highest health care expenditure (as a percent of 
GDP and in real terms as well) and the highest life expectancy (see Table 1). The difference 
between the two groups is that in Cluster 2 (A, B, DK, F, G, NL, N, S, UK, US) we observe a 
moderate drop in the growth rate compared to countries in Cluster 1 (AUS, CA, J, NZ, CH), 
where health expenditure is growing. Cluster 3 countries (CZ, EST, H, PL, SK, MEX, ROK, 
RCH) have the lowest “development” score, have the lowest expenditure and life expectancy. 
In this group the relative growth rate dropped about 50% on average, but remains positive. 
We can observe a greater drop in Hungary and Estonia, a lower one in Poland, Slovakia and 
the Czech Republic and even an increase in Chile. In countries belonging to Cluster 4 (P, E, 
FIN, I, SLO, IRL, GR, IL, IS) we observe the highest drop in the growth rates. The 
development scores of these countries are around the average.  
 
Table 1. Descriptive statistics by cluster and the results of ANOVA 
Cluster Total health 
exp. PPP 
(USD) 2010 
Total health 
exp. as a % of 
GDP (%) 2010 
Life 
expectancy 
(years) 2010 
Average growth 
rate 2000/08 (%) 
 Average growth 
rate 2008/10 (%) 
1 3963.3 10.5 81.2 3.5 4.8 
2 4741.1 11.4 80.0 3.9 2.4 
3 1552.1 7.4 76.4 7.2 3.6 
4 2937.8 9.3 80.6 5.0 -0.5 
Total 3290.8 9.6 79.5 5.0 2.3 
ANOVA-test 
F 18.37 10.10 17.55 5.73 5.75  
p <1% <1% <1% <1% <1% 
 
The four CEE countries examined belong to cluster 3 due to their low development score and 
relatively high drop in the increase of health expenditure. The highest drops in health care 
expenditure can be observed in Hungary. In the rest of the countries the growth of health 
expenditure declined, but remained positive. 
We also examined the association between the drop of GDP growth rates after the crises and 
the relative growth of health expenditure.We have found significant and positive correlation 
(0.68, p=0.0000) between the relative GDP per capita growth (calculated similarly as the 
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relative growth for health expenditure) and the relative growth rate for health expenditure
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(see Figure 3). This suggests that the fall in GDP growth rate is followed by a decline in 
health care spending growth rate. Figure 3 also shows that in some countries health care 
expenditure continued to increase despite the drop or the stagnation in GDP per capita (e.g. 
Luxemburg (L), Germany (D), Switzerland (CH), Canada (CA), Japan (J)). The Czech 
Republic and Slovakia seem to fit the fitted regression line and the drop in the growth rate is 
in line with the drop in GDP. However in Hungary (HU) and Poland (PL), situated below the 
fitted line, the decline in the growth rate of health expenditure was higher than expected based 
on the GDP drop. The same is observed for countries most affected by the crises, Greece 
(GR), Iceland (IS) and Ireland (IRL).  
 
Figure 3. Association between the “relative growth” of health expenditure and GDP per capita 
in OECD countries 
 
Note: Israel (IL) and Luxemburg (L) were excluded from the calculations as outliers. The grey area illustrates 
the 95% confidence interval for the fitted regression line. The X axis indicates the relative growth rate of GDP 
per capita (the average annual growth rate after the crises between 2008 and 2010 divided by the average annual 
growth rate between 2000 and 2008). The Y axis indicates the relative growth rate of health expenditure per 
capita (the average annual growth rate after the crises between 2008 and 2010 divided by the average annual 
                                                          
5
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growth rate between 2000 and 2008). A linear regression was fitted to the observations, the characteristics of the 
regression line are shown on the graph as well. Source of data: OECD health data 2012, OECD statistics. 
 
4. Discussion and conclusions 
The major findings of the study are the following. First, we find that countries with similar 
“development” levels (in terms of health expenditure) reacted quite differently to the 
economic recession. This justifies the application of cluster analysis, which helps to 
distinguish homogenous groups of countries. We found differences in the changes in the 
growth of health expenditure among countries with a high development score: For example 
Canada, Germany, Japan, Australia, New Zealand experience no drop in the growth of health 
expenditure, while in others growth started to halt (e.g. UK, the Netherlands). This also stands 
for the four CEE countries examined.  
Second, the drop in GDP is found to be a strong predictor of the changes in the growth of 
health care expenditure after the economic recession. In most of the countries where the GDP 
drop was higher, the drop in the growth rate of health expenditure was also higher, except for 
the countries like Canada, Japan, Germany and Switzerland. The countries hit hardest by the 
economic crisis have witnessed the biggest decreases in health expenditure growth (like 
Ireland and Greece), which is confirmed by other studies as well (e.g. OECD 2013). 
Regarding the four countries examined, the drop in health expenditure was in line with the 
drop of GDP, except for Hungary, where we observe an even higher drop than expected based 
on the drop of the GD. This might be the result of other parallel policy measures, but also 
indicate the sensitivity of the Hungarian health care financing on the macroeconomic 
environment. 
Since our method only captures the changes in health expenditure and not capable of 
capturing or explaining the structural changes, it is difficult to interpret whether the observed 
decrease in the growth of health expenditure was the result of cost-containment measures 
implemented as a reaction to the crisis. As mentioned in the introduction, these countries have 
been struggling with deficits for the last two decades, and very often “loose fiscal periods“ 
were from time to time followed by austerity measures which resulted in the fluctuation of 
health care expenditure even before the crisis (Boncz et al. 2006; Baji et al. 2012). Thus in 
some cases we cannot claim causality. For example, in Poland there was an ongoing reform of 
the health care system during the examined period, however the cost-containment measures 
were not specifically related to the crisis (Vogler et al. 2013). Regarding the Czech Republic 
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there has been little visible impact of the economic crisis on healthcare. The government even 
significantly increased physicians’ salaries in 2011 by approximately 10-15% from 2012, and 
promised a 1.5 to 3-fold increase in salaries in 2013 (Remešová – Dospiva 2011). Despite 
repeated announcements and attempts since 2006, there has been no massive hospital closing 
and no major increase in patient co-payments. In Hungary, the decreasing drug budget is a 
frequently mentioned example of the negative impact of the recession on the health care (see 
Figure 4). A significant cut of the drug budget was reported from 2011 to 2012. However this 
change is partly due to the fact that full outpatient reimbursement for drugs distributed by 
pharmacies (biological agents with 100% reimbursement) was converted into an “itemized 
reimbursement scheme”, similarly to single-use devices, implants, high-value surgical 
procedures and the high-cost drug therapies, which represent a 34.5 billion HUF amount (Héjj 
2012).
6
 Furthermore, the implementation of a blind biding mechanism of pricing and 
reimbursement of generic drugs also resulted in savings of 35 billion HUF (7 billion HUF as 
co-payment and 28 billion HUF from the National Health Insurance Fund’s drug budget) in 
2012. Taking this into account we might conclude that the effective drug budget was even 
higher in 2012 than in 2011.  
 
Figure 4. The Hungarian budget for prescription drugs, (1 euro = 300 HUF) 
 
                                                          
6
 In addition to this, a budget spent on vaccines by the National Public Health Office is estimated to be 10 billion 
HUF per year.  
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Source: National Health Insurance Fund. Note: Patient co-payments cover co-payments only for reimbursement 
drugs. The amounts of patient co-payments are estimations for the year 2011 and 2012. 
 
According to our knowledge,
7
 only a limited number of studies have been published so far in 
English language peer-reviewed journals on the impact of economic recession on health 
outcomes and in the EU member states CEE countries. The majority of the studies from the 
CEE region are focused on the Baltic countries. According to the findings of these papers, the 
Baltic states have experienced decreases in mortality rates despite the economic recession 
(Kalėdienė – Sauliūnė 2013; Kristjuhan – Taidre 2012). However, Strukcinskiene (2011) 
found that after an improvement since 2002, suicide mortality among the 15-19 age group was 
again high during the economic crisis in 2008-2009 in Lithuania. Analysing national statistics, 
Lai and Habicht (2011) found an observable decline in alcohol consumption in Estonia from 
2008, however the decline can partly be explained by restriction policies which had been 
implemented since 2005.  
Only one paper from Hungary was identified, which examined the association of suicide and 
unemployment rates (Fountoulakis et al. 2014) during this period. Baumbach – Gulis (2014) 
examined eight European countries including the Czech Republic, Slovakia and Poland, 
where the suicide rates increased by 7.6%, 22.7% and 19.3% respectively, from 2000 to 2010.  
In the paper of Vandoros et al. (2013), Poland was used as a comparator country of Greece. 
Based on data from an international survey, the authors found that self-rated health status 
dropped in Greece during the economic recession compared to Poland, where GDP growth 
was still positive in 2009. This finding is supposed to provide evidence on the causality of the 
recession and declining self-rated health status, however the authors also highlight some 
important limitations of using this quasi-experimental approach. Association between self-
                                                          
7
 Based on a literature search in the Medline database (the largest database for biomedical literature) between 1 
January 2008 and 1 May, 2014 with the following search strategy: ("economic downturn"[All Fields] OR 
"economic crisis"[All Fields] OR "financial crisis"[All Fields] OR austerity[All Fields] OR recession[All 
Fields]) AND (("health"[MeSH Terms] OR "health"[All Fields]) OR "health care"[All Fields] OR 
"healthcare"[All Fields]) AND ("Central and Eastern Europe"[All Fields] OR "Central and Eastern 
European"[All Fields] OR "Central Europe"[All Fields] OR "Central European"[All Fields] OR "Eastern 
European"[All Fields] OR "Eastern Europe"[All Fields] OR ("bulgaria"[MeSH Terms] OR "bulgaria"[All 
Fields]) OR Bulgarian[All Fields] OR ("romania"[MeSH Terms] OR "romania"[All Fields]) OR Romanian[All 
Fields] OR ("hungary"[MeSH Terms] OR "hungary"[All Fields]) OR Hungarian[All Fields] OR "Czech 
Republic"[All Fields] OR Czech[All Fields] OR ("slovakia"[MeSH Terms] OR "slovakia"[All Fields]) OR 
Slovak[All Fields] OR Slovakian[All Fields] OR ("slovakia"[MeSH Terms] OR "slovakia"[All Fields] OR 
("slovak"[All Fields] AND "republic"[All Fields]) OR "slovak republic"[All Fields]) OR ("poland"[MeSH 
Terms] OR "poland"[All Fields]) OR Polish[All Fields]) AND ("2008/01/01"[PDAT] : "2014/05/01"[PDAT]). 
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rated health status and physical and mental health is still to be proved, and international 
comparison, namely using Poland as a control country is also not without controversies.  
Also, only a few English language papers published in peer reviewed journals present the 
health care reforms and austerity measures implemented in the CEE countries related the 
financial crisis.
8
 Vogler et al. (2011) analysed pharmaceutical policies applied during the 
financial crisis in 33 European countries (including CEE) using a questionnaire. According to 
the conclusions most of the European countries apply cost-containment measures to control 
pharmaceutical expenditure, regardless of the economic crisis. As for the CEE countries, 
Poland also drafted a law to significantly reform the pharmaceutical reimbursement system in 
order to contain costs despite of positive growth, while in the Baltic countries reforms were 
rather considered as a response to the crises.  
The impact of the economic recession on the analysis of the utilization of health care is a 
potential topic of interest of further research. In the countries examined in this paper, 
unnecessary care is a recognized problem (OECD 2012).
9
 According to the OECD, health 
care systems are generating significant health outputs, such as doctor’s consultation and 
hospital discharges, but there are problems with the quality of health services and the need for 
reforms to improve efficiency (OECD 2012). In this case the potential decrease of health care 
resources due to the economic crises is not necessarily to be interpreted as “we have less 
chance to perform good quality efficient health care”, but rather as “we have less money to 
waste for unnecessary care”.  
The worsening level of quality of care could be another sign of the economic recession. 
However, we have not identified any paper analysing this issue in the CEE region. There are 
some studies, which suggest that service quality is lower in CEE compared to the more 
developed countries. Cserháti et al. (2002) found that the Hungarian mortality rate 4 months 
after a hip fracture operation is significantly higher compared to that in Sweden. Another 
study presented evidence that hospital infection related health outcomes in different risk 
                                                          
8
 Some of the papers provide an overview of the health care system, with a specific emphasis on health care 
reforms (Mitenbergs et al. 2012; Gulácsi et al. 2012; Radu et al. 2009). Mitenbergs et al. (2012) give a detailed 
explanation of the reforms carried out in Latvia due to the financial crises. Gulácsi et al. (2012) gives an 
overview of the health technology assessment systems of Hungary, Poland and the Czech Republic, and provides 
some examples from these countries on budget cuts due to the recession. Radu et al. (2009) focus on the 
challenges due to the financial crisis in Romania. Two papers focus on Croatia (Škaričić 2010; Ostojić et al. 
2012). One of them presents the results of a qualitative study where the recession was identified as one of the 
challenging external factors regarding the perspectives of the Croatian health care system.  
9
 Similarly to Greece, the country with the highest number of MRI and CT scans per 10 000 persons among the 
OECD countries. 
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groups are less favourable in Hungary compared to patients in the United States (Gulácsi et al. 
2000). It would be interesting to examine whether the crisis led to a further decline in service 
quality in the CEE countries.  
Some papers argue that in the period of economic recession there might be a higher need for 
data and research to make evidence-based decisions on cost-containment and budget cuts in 
order to ensure the efficient use of resources (Gulácsi et al. 2012). Although the literature 
linked to the economic crisis is rich and rapidly growing, in the field of health care there has 
only been a limited number of publications related to the CEE countries thus far. This 
problem is not specific to the recent crisis, as sufficient data on epidemiology, disease burden, 
health care utilisation and quality of care are in general lacking in the CEE region for national 
policy makers. As Karanikolos et al. (2013) noted, in the absence of up-to-date morbidity and 
mortality data, the effect of the crisis on health is impossible to analyse.  
Also, there are some studies which suggest that the data which are available are often 
unreliable in these countries (e.g. Péntek et al. 2007; Érsek et al. 2010) As an example, the 
European Collaboration on Dementia (EuroCoDe) workgroup estimated to that there were 
131,995 individuals in Hungary suffering from the disease in 2008, while Hungarian national 
statistics recorded only 7,393 Alzheimer cases in 2007 (Érsek et al. 2010).10 However, in 
order to measure the effect of the recession on health outcomes, valid prevalence and 
incidence data would be essential. The literature is rich in economic crisis related publications 
in health care, but the transferability of research results from more developed countries to the 
CEE countries is very limited due to a series of important differences, including demography, 
standard practice, unit costs, and financing of the health care system.  
The impact of the recession on the role of health technology assessment (HTA) in decision 
making would also be an interesting topic to examine. It is a widely shared opinion that the 
need for health economics and HTA in decision making processes is increasing due to more 
and more serious budget constraints caused by the recession, and increasingly demanding 
policy makers and funders who require greater evidence for new and existing therapies. 
Poland and Hungary established their HTA agencies, but the functioning of these is not 
without notable controversies and weaknesses as described by various authors (Gulácsi et al. 
2012; Ozieranski et al. 2012).  
                                                          
10
 Although dementia can have other etiologies than Alzheimer disease, the gap between the two numbers is too 
large. Data from time-series confirm that it was not a single mistake in 2007 but a systematic error over a 
decade. 
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Appendix 1. 
Appendix Table 1. Results of the PCA analysis 
Number of observations 34 
Number of components. 1 
Trace 3 
Rho 0.7307 
KMO 0.5770 
Component Eigenvalue Difference Proportion Cumulative 
Comp1 2.19 1.51 0.73 0.73 
Comp2 0.69 0.57 0.23 0.96 
Comp3 0.12 . 0.04 1.00 
 
Appendix Table 2. Pairwise correlation matrix of the variables and the PCA score 
 
Health 
expenditure 
PPP US$ 
(2010) 
Health 
expenditure 
% of GDP 
(2010) 
Life 
expectancy 
(2010) 
Development 
score 
Health expenditure PPP 
US$ (2010) 1.0000  - - - 
Health expenditure % of 
GDP (2010)  0.8686 1.0000  - - 
Life expectancy (2010) 0.4910 0.3860 1.0000  - 
Development score 0.9456 0.9107 0.6844 1.0000  
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